Cemex S.A.B. De C.V. ADR (CX) concluded trading on Wednesday at a closing price of $6.66, with 5.75 million shares of worth about $38.32 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -0.30% during that period and on February 19, 2025 the price saw a loss of about -0.89%. Currently the company’s common shares owned by public are about 1.51B shares, out of which, 1.51B shares are available for trading.
Stock saw a price change of 0.60% in past 5 days and over the past one month there was a price change of 24.25%. Year-to-date (YTD), CX shares are showing a performance of 18.09% which decreased to -13.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.00 but also hit the highest price of $9.27 during that period. The average intraday trading volume for Cemex S.A.B. De C.V. ADR shares is 9.49 million. The stock is currently trading 6.45% above its 20-day simple moving average (SMA20), while that difference is up 13.41% for SMA50 and it goes to 6.99% higher than SMA200.
Cemex S.A.B. De C.V. ADR (NYSE: CX) currently have 1.51B outstanding shares and institutions hold larger chunk of about 31.13% of that.
The stock has a current market capitalization of $10.07B and its 3Y-monthly beta is at 1.46. PE ratio of stock for trailing 12 months is 21.73, while it has posted earnings per share of $0.31 in the same period. Its PEG reads 1.55 and has Quick Ratio of 0.58 while making debt-to-equity ratio of 0.55. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CX, volatility over the week remained 2.38% while standing at 3.64% over the month.
Stock’s fiscal year EPS is expected to rise by 11.01% while it is estimated to increase by 15.49% in next year. EPS is likely to shrink at an annualized rate of 13.98% for next 5-years, compared to annual growth of 61.93% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on December 11, 2024 offering an Underperform rating for the stock and assigned a target price range of between $6 and $5 to it. Coverage by JP Morgan stated Cemex S.A.B. De C.V. ADR (CX) stock as a Neutral in their note to investors on October 29, 2024, suggesting a price target of $6 for the stock. On October 08, 2024, RBC Capital Mkts Upgrade their recommendations, while on August 21, 2024, JP Morgan Resumed their ratings for the stock with a price target of $8. Stock get an Overweight rating from Barclays on July 31, 2024.
